The landscape of canine health supplements has had a shake-up. A recent class action lawsuit has brought the spotlight on Nutramax Laboratories, Inc. and its canine supplements branded under Cosequin®. If you bought specific Cosequin® products for personal use in California between May 3, 2016, and May 6, 2022, you might be in line for a share of an $11.5 million settlement.
The lawsuit alleged that Nutramax misrepresented the benefits and effectiveness of their canine supplements in both advertising and packaging. While the company denies all allegations of wrongdoing, this settlement intends to compensate those who feel misled. The settlement has been approved by a court, allowing eligible consumers to seek financial redress.
But who exactly is eligible? The class includes all California residents who bought certain Cosequin® products during the specified timeframe. These include popular items like Cosequin® DS Maximum Strength Chewable Tablets and their variations, which were intended for personal household use and not for commercial resale.
For those eligible, submitting a claim is the next step. Consumers can fill out a claim form either online at
www.CosequinCASettlement.com or mail it, as long as it’s postmarked by July 21, 2026. Compensation can reach up to $25 per unit purchased, with a maximum claim amount of $150 per household. However, if the valid claims exceed the settlement fund, each member’s payout will be adjusted proportionally.
It’s essential to be aware of other options as well. If you prefer not to participate in the settlement, you have until June 22, 2026, to submit an opt-out request. This allows you to retain the right to pursue separate legal actions against Nutramax. Alternatively, you can object to any part of the settlement, including attorneys’ fees.
For complete details, interested parties can review the Long Form Notice available at the settlement website or call the toll-free number provided. A Fairness Hearing is scheduled for August 13, 2026, where the court will consider whether to approve the settlement and any objections.
As consumers gather to claim their rightful compensation, this case serves as a reminder of the importance of transparency in product advertising—especially in the world of pet health. Pet owners often make purchasing decisions based on trust and efficacy; when that trust is broken, the consequences can be significant.
For continued updates on this settlement and to ensure your rights are protected, check
www.CosequinCASettlement.com and stay informed about the next steps leading to the Fairness Hearing. Let’s advocate for our pets and make sure we hold companies accountable for their claims.